investordatabase.org

Biovance Capital

biovancecapital.com Direct investor

Biovance Capital is a Portuguese life sciences venture capital firm managing Biovance Capital Fund I, a €60 million fund focused on early-stage biotech. It invests in seed and Series A rounds in drug development companies across Europe, with a focus on Southern Europe.

Biovance Capital is a venture capital firm headquartered in Lisbon, Portugal. It invests directly in companies, from seed to Series A, in biotech, biopharma, therapeutics and life sciences. 60M € under management, as it reports.

“We invest in early-stage companies at seed and Series A rounds across Europe, with a focus in Southern countries.”

— Biovance Capital, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series A
Headquarters
Lisbon, Portugal
Invests in
Europe, Southern Europe
Sectors
biotech, biopharma, therapeutics, life sciences
Assets under management
60M €

Team, as Biovance Capital publishes it

  • Ricardo Perdigão Henriques, PhD Managing Partner
  • João Incio, MD, PhD General Partner
  • André Albergaria, PhD Principal
  • Peter Villax Non-Executive Partner
  • João Botelho CFO
  • Hannah Franklin, PhD Associate
  • Raquel Melo Financial Manager
  • Yunyun Sun, PhD Fellow
  • Ana Agostinho Office Manager
  • Beatriz Martins Ferreira Compliance Officer
  • Ana Pinheiro External Sustainability Consultant

Names and roles exactly as listed on biovancecapital.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Biovance Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 13817 · added 2026-10-19 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under